Adage Capital Partners’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.7M | Hold |
|
|||||
|
2024
Q4 | $14.3M | Sell |
|
|||||
|
2024
Q3 | $29.7M | Sell |
|
|||||
|
2024
Q2 | $25.6M | Buy |
|
|||||
|
2024
Q1 | $40.8M | Sell |
|
|||||
|
2023
Q4 | $23.6M | Hold |
|
|||||
|
2023
Q3 | $23.3M | Buy |
|
|||||
|
2023
Q2 | $23.7M | Sell |
|
|||||
|
2023
Q1 | $24.4M | Buy |
|
|||||
|
2022
Q4 | $3.26M | Buy |
|
|||||
|
2022
Q3 | $6.96M | Buy |
|
|||||
|
2022
Q2 | $12.1M | Buy |
|
|||||
|
2022
Q1 | $7.14M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Buy |
|
|||||
|
2021
Q3 | $17M | Buy |
|
|||||
|
2021
Q2 | $22M | Buy |
|
|||||
|
2021
Q1 | $21.6M | Buy |
|
|||||
|
2020
Q4 | $18.5M | Buy |
|
|||||
|
2020
Q3 | $21M | Buy |
|